Zionsville, IN, United States of America

Laurie M Poteet

This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laurie M Poteet. Retrieved from https://idiyas.com/inventor/laurie-m-poteet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 77(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Laurie M Poteet: Innovator in Glycosylation Processes

Introduction

Laurie M Poteet is a notable inventor based in Zionsville, IN (US). She has made significant contributions to the field of glycosylation processes, particularly in the preparation of nucleosides. Her innovative work has led to the development of a unique stereoselective glycosylation process.

Latest Patents

Laurie holds a patent for a "Stereoselective glycosylation process for preparing beta- and alpha-anomer enriched 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides." This process involves reacting a concentrated alpha- or beta-anomer enriched 2-deoxy-2,2-difluorocarbohydrate or 2-deoxy-2-fluorocarbohydrate with a nucleobase derivative in a high boiling inert solvent. She has 1 patent to her name.

Career Highlights

Laurie is currently employed at Eli Lilly and Company, where she continues to advance her research in the pharmaceutical field. Her work is crucial in developing new therapeutic agents that can benefit patients.

Collaborations

Throughout her career, Laurie has collaborated with esteemed colleagues such as Ta-Sen Chou and Douglas P Kjell. These partnerships have enhanced her research and contributed to the success of her projects.

Conclusion

Laurie M Poteet is a pioneering inventor whose work in glycosylation processes has made a significant impact in the field of pharmaceuticals. Her innovative approaches and collaborations continue to drive advancements in this important area of research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…